Register now for these public workshops September 17 and 18 in Bethesda, MD. Hear the latest information on products and inhibitors.
Findings show that as people with hemophilia age, they will experience cardiovascular disease, which will need to be managed closely.
MASAC releases new documents on VWD, bypassing agents, HCV and treatment recommendations on current products.
The latest online educational activity discusses challenges in assessing and treating children with hemophilia from a nursing perspective.
“Managing Age-Related Clinical Issues in Hemophilia,” covers hypertension, cardiovascular disease, obesity, bone health and HCV.
The latest online educational activity from Medscape, “The Management of Hemophilia: A Primer,” became available on Tuesday, June 2, 2015.
An ongoing clinical trial for genotype 1 patients with chronic hepatitis C infection (HCV), now expanded to include genotypes 2, 3 and 4.
This chapter gives an overview of hemophilia A and B, and emphasizes the nurses' role as part of the comprehensive care provided by HTCs.
This online tool provides comprehensive care teams with information on helping patients with hemophilia maintain healthy joints.
Researchers and clinicians should register now for FVIII inhibitor symposium in Ohio.
eNewsletter Sign Up
Steps for Living
Victory for Women
Donate Your Car